HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/5/R1473    most recent 90699.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Abdel-Rahman, E. M. Articles by Siragy, H. M. Search for Related Content PubMed PubMed Citation Articles by Abdel-Rahman, E. M. Articles by Siragy, H. M.

TRANSLATIONAL PHYSIOLOGY

Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT₁ and AT₂ receptors

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia

Submitted 18 August 2008 ; accepted in final form 15 September 2008

ABSTRACT

Diabetes is associated with increased production of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE]. The mechanisms involved in this process remain unclear. We hypothesized that hyperglycemia and angiotensin II (ANG II) regulate renal 12(S)-HETE production via a balance between angiotensin AT₁ and AT₂ receptors activities. Using a microdialysis technique, renal interstitial fluid (RIF) levels of ANG II and 12(S)-HETE were monitored in normal control and streptozotocin-induced diabetic rats at baseline and then weekly thereafter for 12 wk. In a second group of normal and diabetic rats, 3 wk after development of diabetes, we monitored RIF 12(S)-HETE levels in response to acute AT₁ receptor blockade with valsartan or AT₂ receptor blockade with PD123319 individually or combined. Two weeks after induction of diabetes there was a 404% increase in ANG II (P < 0.05), a 149% increase in 12S-HETE (P < 0.05), and a 649% increase in urinary albumin excretion (P < 0.05). These levels remained elevated throughout the study. PD123319 given alone had no effect on 12(S)-HETE. Valsartan decreased 12(S)-HETE by 61.6% (P < 0.0001), a response that was abrogated when PD123319 was given with valsartan. These data demonstrate that hyperglycemia increases renal ANG II and 12(S)-HETE levels. The increase in 12(S)-HETE is mediated via AT₁ receptor. The attenuation of the effects of AT₁ receptor blockade by PD123319 suggests that AT₂ receptor contributes to the downregulation of renal 12(S)-HETE production.

diabetes mellitus; angiotensin II; kidneys; urinary albumin excretion